Legal Representation
Attorney
J. Matthew Buchanan
USPTO Deadlines
Next Deadline
185 days remaining
NOA E-Mailed - SOU Required
Due Date
July 30, 2026
Extension Available
Until January 30, 2027
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 7, 2026 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 6, 2026 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 6, 2026 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 6, 2026 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 30, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 30, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 30, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 29, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 29, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 30, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 30, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 30, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 30, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 30, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 5, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 5, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 2, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 2, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 2, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 1, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 1, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 2, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 2, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 2, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 21, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 13, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccines; Modified cells for medical or clinical use; Pharmaceuticals for the prevention or treatment of COVID19; Pharmaceuticals for the prevention or treatment of infection with respiratory syncytial virus (RSV); Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use; Medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing infection, disease, or disorders; Medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for treating infection, disease, or disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention of infection, disease, or disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of infection, disease, or disorders
Classification
International Classes
005